Related Experiment Video
Updated: May 20, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Essential thrombocythemia in a young man treated for myocardial infarction
1Department of Rehabilitation Medicine, Changi General Hospital, Singapore. shrikantpande@yahoo.co.uk
Abstract:
Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm which can cause thrombohaemorrhagic complications usually involving microvasculature. Medium-sized arterial thrombosis has been reported, but coronary occlusion usually occurs with additional risk factors, for example, smoking, hyperlipidaemia and so on. We present a case of acute myocardial infarction (AMI) in a young man (29 years) with ET but without any coronary artery associated risk factors. He was successfully treated for his AMI and ET with cytoreductive treatment and has recovered well. Due to automated platelet counting, ET is being increasingly identified; early detection can prevent long-term complications, and patients can have normal life span.
Related Concept Videos
Myocarditis III: Medical Management
Venous Thrombosis III: Interprofessional Care
Myocarditis II: Clinical Features and Diagnostic Tests
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Myocarditis I: Introduction
Acute Coronary Syndrome I: Introduction

